Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 51655-427

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 51655-427). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

Image (Cyclobenzaprine HCl Tabs Structure)
Chemical structure diagram of cyclobenzaprine hydrochloride showing its molecular framework and formula components.*
FDA Label Image

Label (51655 427 52 Rev A 04 22 Nhc)

Label (51655 427 52   Rev A 04 22 Nhc)
The label for Cyclobenzaprine Hydrochloride Tablets USP, 5 mg, features detailed product information including a quantity of 30 tablets. It specifies prescription-only use, storage instructions at 20°-25°C (68°-77°F), and caution to keep out of reach of children. The label includes the NDC 51655-427-52 and identifies Northwind Health Company, LLC as the labeler.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.